Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zengjun Liu

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Environmental Pollution (Barking, Essex : 1987)|September 23, 2014
A whole-cell bioreporter approach for the genotoxicity assessment of bioavailability of toxic compounds in contaminated soil in ChinaYizhi Song, Bo Jiang, Sicong Tian, et al.
Journal of Cancer Research and Clinical Oncology|April 28, 2022
Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in ChinaXiao Han, Jun Guo, Xiaoyong Tang, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trialXiao Han, Xiaoyong Tang, Hui Zhu, et al.
Cell Proliferation|April 24, 2026
Human Pancreatic Cancer OrganoidsAina He, Xiaolin Lin, Xiaozhe Qian, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Environmental Pollution (Barking, Essex : 1987)|September 23, 2014
A whole-cell bioreporter approach for the genotoxicity assessment of bioavailability of toxic compounds in contaminated soil in ChinaYizhi Song, Bo Jiang, Sicong Tian, et al.
Journal of Cancer Research and Clinical Oncology|April 28, 2022
Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in ChinaXiao Han, Jun Guo, Xiaoyong Tang, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trialXiao Han, Xiaoyong Tang, Hui Zhu, et al.
Cell Proliferation|April 24, 2026
Human Pancreatic Cancer OrganoidsAina He, Xiaolin Lin, Xiaozhe Qian, et al.
Pageof 3